Further insight into the role of BMP1 in LDLR metabolism, including the development of a humanised LDLR mouse model, will extend our understanding of the biological mechanisms controlling plasma LDL‐C and could lead to new therapeutic targets for the treatment of hypercholesterolaemia. The gene discussed is LDLR; the disease is Hypercholesterolemia.